Pricing Log in Create free account

Aldeyra Therapeutics, Inc. (ALDX) vs Elicio Therapeutics, Inc. (ELTX)

Aldeyra Therapeutics, Inc. and Elicio Therapeutics, Inc. are both Biotechnology companies. Aldeyra Therapeutics, Inc. and Elicio Therapeutics, Inc. are of similar size ($37.9M and $37.2M). Across the 9 metrics below, Aldeyra Therapeutics, Inc. leads on 8 and Elicio Therapeutics, Inc. on 1.

Valuation

Metric ALDX ELTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.01 9.40
P/B 1.02 3.69 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.56 9.02
Earnings yield (60.94%) (142.76%) (32.88%)
Free cash flow yield (57.10%) (129.21%) (23.13%)

Profitability

Metric ALDX ELTX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.48%) (774.56%) (51.96%)
Return on assets (34.80%) (124.36%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALDX ELTX Biotechnology median
Revenue growth (TTM) — 921.02% 6.76%
EPS growth (last fiscal year) 40.43% 39.29% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALDX ELTX Biotechnology median
Debt to equity 0.00 1.20 0.00
Current ratio 4.91 2.77 4.97
Net debt to EBITDA 1.52 0.25 1.01

Dividend

Metric ALDX ELTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALDX ELTX Biotechnology median
Market cap 37.16m 37.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack